Developing an Ultrasensitive Glutathione Fluorescence Probe Using a Screen Strategy: Tracking Stroke-Induced Ferroptosis Via <i>in Vivo</i> and <i>in Vitro</i> Imaging

Xiaoxing Xiong,Yingze Ye,Xiaoyang Gao,Hua Zhu,Wei Hu,Chunya Li,Hong‐Ping Deng,Lijuan Gu
DOI: https://doi.org/10.2139/ssrn.3975252
2021-01-01
SSRN Electronic Journal
Abstract:In recent years, ferroptosis and glutathione (GSH), an important antioxidant in organisms, have been considered to be closely related. Ferroptosis increases the depletion of GSH by suppressing the cystine glutamate transporter (System Xc–). However, very few tools can induce and detect intracellular GSH (130-140 nM) fluctuations during ferroptosis in situ. Additionally, due blood-brain barriers (BBB) limitations, assessing ferroptosis in brain tissue is very challenging, which tremendously restricts the development of new strategies to target, detect, and hinder ferroptosis. Therefore, we successfully synthesized a series of BODIPY-based fluorescent probes, WD-1-SH, WD-2-SH, and WD-3-SH, and detected many properties, including the penetration capacity of BBB, sensitivity to GSH and tissue penetration depth of excitation and emission. In vitro experiments demonstrated that among the probes, WD-1-SH exhibited the highest sensitivity in response to GSH; however, WD-2-SH exhibited higher sensitivity in vivo. Overall, this study successfully corroborated that ferroptosis occurs following a stroke by constructing a middle cerebral artery occlusion (MCAO) mouse model in vivo and inducing oxygen deprivation/reperfusion (ODG/RX) in vitro and used the above probes to efficiently detect GSH alterations during ischaemic ferroptosis.
What problem does this paper attempt to address?